Answer ALS Teams with GATC, Pennington and Tulane for AI Drug Development
July 23, 2025
Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative diseases.